Researchers sought to identify the importance of providing an effective, appropriate self-care intervention to heart failure patients especially if they have depressive symptoms.
A reduced dose of prasugrel compared with the standard dose of ticagrelor was associated with maintained anti-ischemic efficacy and safety in elderly or low-weight patients with acute coronary syndrome.
Time to telemedicine diagnosis was found to be a useful parameter in assessing the effectiveness of telemedicine in patients who have experienced myocardial infarction.
The Food and Drug Administration approved the 50cc temporary Total Artificial Heart System developed and manufactured by SynCardia Systems, LLC as a bridge to heart transplant for patients who are at imminent risk for death from biventricular failure.
The performance of a European Society of Cardiology algorithm in ruling out acute myocardial infarction without ST-elevation was comparable in patients with and without diabetes mellitus.
For patients with heart failure discharged to a skilled nursing facility and then home, the risk for readmission is highest during the first 2 days at home and is attenuated with a longer SNF length of stay.